Editorial: Childbirth, American style

Autor: Ryan Gm

Publikováno v: JAMA. 233(5)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::175e96ad0e7f943637b0e35636ec8935
https://pubmed.ncbi.nlm.nih.gov/1173858

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

DMPC/Chol liposomal copper CX5461 is therapeutically superior to a DSPC/Chol formulation.

Autor: Leung AWY; Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC, Canada; Department of Chemistry, University of British Columbia, Vancouver, BC, Canada; Cuprous Pharmaceuticals Inc., Vancouver, BC, Canada; Nanomedicine Innovation Network, University of British Columbia, Vancouver, BC, Canada. Electronic address: aleung@cuprous.ca., Chen KTJ; Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC, Canada; The Interdisciplinary Oncology Program, University of British Columbia, Vancouver, BC, Canada; Nanomedicine Innovation Network, University of British Columbia, Vancouver, BC, Canada., Ryan GM; Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC, Canada., Anantha M; Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC, Canada., Wretham N; Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC, Canada., Nosrati Z; Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC, Canada; Cuprous Pharmaceuticals Inc., Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada; Nanomedicine Innovation Network, University of British Columbia, Vancouver, BC, Canada., Heroux D; Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC, Canada; The Interdisciplinary Oncology Program, University of British Columbia, Vancouver, BC, Canada., Wang L; Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC, Canada., Chow N; Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC, Canada., Dai Z; Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC, Canada., Bally MB; Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC, Canada; Cuprous Pharmaceuticals Inc., Vancouver, BC, Canada; The Interdisciplinary Oncology Program, University of British Columbia, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; Nanomedicine Innovation Network, University of British Columbia, Vancouver, BC, Canada.

Publikováno v: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2022 May; Vol. 345, pp. 75-90. Date of Electronic Publication: 2022 Mar 05.